Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kura Oncology (KURA) FCF Margin (2025 - 2026)

Kura Oncology has reported FCF Margin over the past 2 years, most recently at 470.75% for Q1 2026.

  • Quarterly FCF Margin rose 4115.0% to 470.75% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 117.9% through Mar 2026, changed N/A year-over-year, with the annual reading at 104.76% for FY2025, 35316.0% down from the prior year.
  • FCF Margin was 470.75% for Q1 2026 at Kura Oncology, down from 649.87% in the prior quarter.
  • Over five years, FCF Margin peaked at 649.87% in Q4 2025 and troughed at 511.9% in Q1 2025.